Vimarsana
Biggest News Aggregation in the World

Page 11 - Mark Schena News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Schena. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Schena Today - Breaking & Trending Today

California Biotech Executive Is Guilty in $77 Million Blood-Testing Scheme - Vimarsana News

California Biotech Executive Is Guilty in $77 Million Blood-Testing Scheme

Arrayit Corporation claimed to have invented a technology to test for any disease using a drop of blood, including Covid-19 and cancer.

Tech CEO convicted in COVID-19, allergy test fraud case - Vimarsana News

Tech CEO convicted in COVID-19, allergy test fraud case

SAN FRANCISCO — A Silicon Valley executive who prosecutors said lied to investors about inventing technology that tested for allergies and COVID-19 using only a few drops of blood and charged...

Tech CEO convicted in COVID-19, allergy test fraud case - Vimarsana News

Tech CEO convicted in COVID-19, allergy test fraud case

SAN FRANCISCO (AP) -- A Silicon Valley executive who prosecutors said lied to investors about inventing technology that tested for allergies and COVID-19

Tech CEO convicted in COVID-19, allergy test fraud case - Vimarsana News

Tech CEO convicted in COVID-19, allergy test fraud case

A Silicon Valley executive who prosecutors said lied to investors about inventing technology that tested for allergies and COVID-19 using only a few drops of blood and charged up to US$10,000 per allergy test was found guilty of health care fraud, authorities announced Friday.

Source: ctvnews.ca
Feds Rip Exec's 'Culture Of Lies' As COVID Fraud Trial Wraps - Vimarsana News

Feds Rip Exec's 'Culture Of Lies' As COVID Fraud Trial Wraps

Prosecutors urged a California federal jury during closings Tuesday to find Arrayit's president guilty of fraud and conspiracy for his "culture of lies," which allegedly involved duping insurers, patients and investors with inaccurate allergy and COVID-19 tests, while defense counsel argued that the charges are built upon incomplete evidence and non-credible witness testimony.

Source: law360.com